Pfizer revs up to leave GSK in the dust as maternal RSV vax granted FDA breakthrough tag
Pfizer revs up to leave GSK in the dust as [...]
Pfizer revs up to leave GSK in the dust as [...]
FDA slaps hold on Finch’s C. diff med to get [...]
RedHill’s second-try COVID pill staves off hospitalization in phase 2 [...]
AbbVie bets $130M on UCB spinout, bagging early-phase Alzheimer’s and [...]
Pfizer fails phase 3 C. diff vaccine test but still [...]
Gemini CEO out the door as 80% of staff laid [...]
FDA sticks a fork in Reata’s treatment for chronic kidney [...]
Amryt’s shares tumble as FDA stiff-arms skin treatment, a month [...]
Russian invasion of Ukraine could affect more than 200 clinical [...]
AbbVie ditches fibrosis program it paid Morphic $20M for in [...]